The research group led by Dr. Elena Herrera-Carrillo focuses on developing innovative genetic and molecular strategies to combat viral infections and advance gene therapy technologies. Her team integrates RNA biology, genome editing, promoter engineering, peptide-based antivirals, and viral vector design to create precise, safe, and durable therapeutic approaches.
The group investigates the molecular mechanisms underlying virus–host interactions with the goal of developing next-generation therapies capable of achieving long-term, treatment-free viral control.